These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 27574945)
1. Transition From Inhaled Treprostinil to Selexipag in Pulmonary Arterial Hypertension. El-Kersh K; Smith JS Am J Ther; 2017; 24(5):e620-e621. PubMed ID: 27574945 [No Abstract] [Full Text] [Related]
2. Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study. Frost A; Janmohamed M; Fritz JS; McConnell JW; Poch D; Fortin TA; Miller CE; Chin KM; Fisher M; Eggert M; McEvoy C; Benza RL; Farber HW; Kim NH; Pfister T; Shiraga Y; McLaughlin V J Heart Lung Transplant; 2019 Jan; 38(1):43-50. PubMed ID: 30391194 [TBL] [Abstract][Full Text] [Related]
3. Rapid transition from oral selexipag to parenteral treprostinil in a patient with mixed-etiology pulmonary hypertension. Radosevich JJ; DeChristopher A; Irandost M; Fann J; Feldman J Am J Health Syst Pharm; 2020 Jul; 77(15):1208-1212. PubMed ID: 32620953 [TBL] [Abstract][Full Text] [Related]
4. Different efficacy of inhaled and oral medications in pulmonary hypertension. AbuHalimeh BJ; Parambil JG; Tonelli AR Heart Lung; 2017; 46(4):334-337. PubMed ID: 28527831 [TBL] [Abstract][Full Text] [Related]
5. Transition from treprostinil to selexipag in patients with pulmonary arterial hypertension: Case series. Fanous SM; Janmohamed M Am J Health Syst Pharm; 2018 Dec; 75(23):1877-1881. PubMed ID: 30301721 [TBL] [Abstract][Full Text] [Related]
6. Transition of Intravenous Treprostinil to Oral Therapy in a Patient with Functional Class IV Chronic Thromboembolic Pulmonary Hypertension. Thurber KM; Williams BM; Bates RE; Frantz RP Pharmacotherapy; 2017 Aug; 37(8):e76-e81. PubMed ID: 28513869 [TBL] [Abstract][Full Text] [Related]
7. Transition from intravenous treprostinil to enteral selexipag in an infant with pulmonary arterial hypertension. Koo R; Lo J; Bock MJ Cardiol Young; 2019 Jun; 29(6):849-851. PubMed ID: 31379316 [TBL] [Abstract][Full Text] [Related]
8. Right Heart Catheterization Further Confirms Successful Transition from Parenteral Prostanoid to Oral Selexipag. Lázaro Salvador M; Escribano Subías P; Rodriguez Padial L Arch Bronconeumol (Engl Ed); 2019 Jul; 55(7):393-394. PubMed ID: 30910272 [No Abstract] [Full Text] [Related]
9. Successful transition from Treprostinil to Selexipag in patient with severe pulmonary arterial hypertension. Furukawa A; Tamura Y; Iwahori H; Goto M; Ohashi N; Okabe T; Kawamura A BMC Pulm Med; 2017 Oct; 17(1):135. PubMed ID: 29073911 [TBL] [Abstract][Full Text] [Related]
16. Inhaled treprostinil for the treatment of pulmonary arterial hypertension. Poms A; Kingman M Crit Care Nurse; 2011 Dec; 31(6):e1-10. PubMed ID: 22135338 [TBL] [Abstract][Full Text] [Related]
17. Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series. Enderby CY; Soukup M; Al Omari M; Zeiger T; Burger C J Clin Pharm Ther; 2014 Oct; 39(5):496-500. PubMed ID: 24806480 [TBL] [Abstract][Full Text] [Related]
18. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262 [TBL] [Abstract][Full Text] [Related]
19. Transition From Subcutaneous or Inhaled Treprostinil to Oral Treprostinil at Home in Patients With Pulmonary Arterial Hypertension: A Retrospective Case Series. Ackerbauer KA; Tandon R J Pharm Pract; 2018 Apr; 31(2):163-166. PubMed ID: 28464760 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension. Channick RN; Olschewski H; Seeger W; Staub T; Voswinckel R; Rubin LJ J Am Coll Cardiol; 2006 Oct; 48(7):1433-7. PubMed ID: 17010807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]